DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vaccine

Jul 15, 2020

New Delhi [India], July 15 : The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide...

New initiative by Drug Controller General of India to boost ease of doing business

Feb 15, 2024

In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing the ease of doing business...

Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccine

Jan 04, 2021

New Delhi [India], January 4 : The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila...

AstraZeneca gets approval to import breast cancer treatment drug in India

May 03, 2023

AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI)...

Zydus Cadila submits additional data to DCGI: Sources

Jul 27, 2021

New Delhi [India], July 27 : Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety to India's drug regulator Drugs Controller...

DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupiravir

Dec 28, 2021

Mumbai (Maharashtra) [India], December 28 : Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch...